Osborne Clarke has advised Bone Therapeutics on the deal. Bone Therapeutics acquired a majority stake in Medsenic. This combination of Bone Therapeutics and Medsenic has created...
Bone Therapeutics’ Acquisition of a Majority Stake in Medsenic
Bone Therapeutics’ €16 Million Loan Financing
Osborne Clarke advised Bone Therapeutics on the deal. Bone Therapeutics, the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, received...